Erratum: Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 (Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 (2004) 41(4) (563–572), (S0896627304000194) (10.1016/s0896-6273(04)00019-4));Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3

Neuron

Volumn 41, Issue 4, 2004, Pages 563-572

  Guo, Huang ^a   Liu, Dong ^b   Gelbard, Harris ^b   Cheng, Tong ^b   Insalaco, Rae ^a   Fernández, José A ^c   Griffin, John H ^c   Zlokovic, Berislav V ^a,b  

^a Socratech Laboratories   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; PROTEIN P53; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR ANTIBODY; STAUROSPORINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; ENZYME ACTIVATION; FETUS; GENE DELETION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 1342269932     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2023.12.001     Document Type: Erratum

References (51)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science. 298:2002;846-850.
2. Alves da Costa C., Mattson M.P., Ancolio K., Checler F. The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart. J. Biol. Chem. 278:2003;12064-12069.
3. Arnoult D., Parone P., Martinou J.C., Antonsson B., Estaquier J., Ameisen J.C. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J. Cell Biol. 159:2002;923-929.
4. Ayata C., Ayata G., Hara H., Mattews R.T., Beal M.F., Ferrante R.J., Endres M., Kim A., Christie R.H., Waeber C.et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J. Neurosci. 17:1997;6908-6917.
5. Bahou W.F. Protease-activated receptors. Curr. Top. Dev. Biol. 54:2003;343-369.
6. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterband J.D., Ely E.W., Fisher C.J. Jr. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:2001;699-702.
7. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis. two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
8. Brüne B., Schneiderhan N. Nitric oxide evoked p53-accumulation and apoptosis. Toxicol. Lett. 139:2003;119-123.
9. Budd S.L., Tenneti L., Lishnak T., Lipton S.A. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA. 97:2000;6161-6166.
10. Cheng T., Liu D., Griffin J.H., Fernandez J.A., Castellino F., Rosen E.D., Fukudome K., Zlokovic B.V. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat. Med. 9:2003;338-342.
11. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158:2002;507-517.
12. Coughlin S.R. Thrombin signaling and protease-activated receptors. Nature. 407:2000;258-264.
13. Coughlin S.R., Camerer E. PARticipation in inflammation. J. Clin. Invest. 111:2003;25-27.
14. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
15. Djebaili M., Rondouin G., Baille V., Bockaert J. p53 and Bax implication in NMDA induced-apoptosis in mouse hippocampus. Neuroreport. 11:2000;2973-2976.
16. Domotor E., Benzakour O., Griffin J.H., Yule D., Fukudome K., Zlokovic B.V. Activated Protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood. 101:2003;4797-4801.
17. Donovan F.M., Cunningham D.D. Signaling pathways involved in thrombin-induced cell protection. J. Biol. Chem. 273:1998;12746-12752.
18. Du Y.S., Bales K.R., Dodel R.C., Hamilton-Byrd E., Horn J.W., Czilli D.L., Simmons L.K., Ni B., Paul S.M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 94:1997;11657-11662.
19. Fernandez J.A., Xu X., Liu D., Zlokovic B.V., Griffin J.H. Recombinant murine activated protein C is neuroprotective in a murine ischemic stroke model. Blood Cells Mol. Dis. 30:2003;271-276.
20. Gabriel B., Sureeau F., Casselyn M., Teissie J., Petit P.X. Retroactive pathway involving mitochondria in electroloaded cytochrome c-induced apoptosis. Exp. Cell Res. 289:2003;195-210.
21. Griffin J.H., Zlokovic B.V., Fernandez J.A. Activated protein C. potential therapy for severe sepsis, thrombosis, and stroke Semin. Hematol. 39:2002;197-205.
22. Isermann B., Sood R., Pawlinski R., Zogg M., Kalloway S., Degen J.L., Mackman N., Weiler H. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat. Med. 9:2003;331-337.
23. Jordan J., Galindo M.F., Gonzalez-Garcia C., Cena V. Role and regulation of p53 in depolarization-induced neuronal death. Neuroscience. 122:2003;707-715.
24. Joyce D.E., Gelbert L., Ciaccia A., DeHoff B., Grinnell B.W. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J. Biol. Chem. 276:2001;11199-11203.
25. Kemp J.A., McKernan R.M. NMDA receptor pathways as drug targets. Nat. Neurosci. 5:2002;1039-1042.
26. Kuliopulos A., Covic L., Seeley S.K., Sheridan P.J., Helin J., Costello C.E. Plasmin desensitization of the PAR1 thrombin receptor. kinetics, sites of truncation, and implications for thrombolytic therapy Biochemistry. 38:1999;4572-4585.
27. Le D.A., Lipton S.A. Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging. Drugs Aging. 18:2001;717-724.
28. Matys T., Strickland S. Tissue plasminogen activator and NMDA receptor cleavage. Nat. Med. 9:2003;371-373.
29. McInnis J., Wang C., Anastasio N., Hultman M., Ye Y., Salvemini D., Johnson K.M. The role of superoxide and nuclear factor-kappaB signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. J. Pharmacol. Exp. Ther. 301:2002;478-487.
30. Morrison R.S., Kinoshita Y., Johnson M.D., Guo W., Garden G.A. p53-dependent cell death signaling in neurons. Neurochem. Res. 28:2003;15-27.
31. Mosnier L.O., Griffin J.H. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease activated receptor-1 and endothelial protein C receptor. Biochem. J. 373:2003;65-70.
32. Nakanishi-Matsui M., Zheng Y.W., Sulciner D.J., Welss E.J., Ludeman M.J., Coughlln S.R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature. 404:2000;609-613.
33. Nicole O., Docagne F., Ali C., Margaili I., Carmeliet P., MacKenzie E.T., Vilien D., Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 7:2001;59-64.
34. Okamoto S., Li Z., Ju C., Scholzke M.N., Mathews E., Cui J., Salvesen G.S., Bossy-Wetzel E., Lipton S.A. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA. 99:2002;3974-3979.
35. Paitel E., Sunyach C., Alves da Costa C., Bourdon J.C., Vincent B., Checler F. Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J. Biol. Chem. 279:2004;612-618.
36. Penninger J.M., Kroemer G. Mitochondria, AIF and caspases-rivaling for cell death execution. Nat. Cell Biol. 5:2003;97-99.
37. Riewald M., Petrovan R.J., Donner A., Mueller B.M., Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 296:2002;1880-1882.
38. Ruf W. PAR1 signaling. more good than harm? Nat. Med. 9:2003;258-260.
39. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 404:2000;892-897.
40. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., Schreiber S.S. Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment. Exp. Neurol. 145:1997;81-88.
41. Shibata M., Kumar S.R., Amar A., Fernandez J.A., Hofman F., Griffin J.H., Zlokovic B.V. Anti-Inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 103:2001;1799-1805.
42. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K.G., Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. USA. 97:2000;2264-2269.
43. Striggow F., Riek-Burchardt M., Kiesel A., Schmidt W., Henrich-Noack P., Breder J., Krug M., Reymann K.G., Reiser G. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14:2001;595-608.
44. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M.et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
45. Tenneti L., Lipton S.A. Involvement of activated caspase-3 like protease in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 74:2000;134-142.
46. Tieu K., Zuo D.M., Yu P.H. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells. involvement of bcl-2 and p53 proteins J. Neurosci. Res. 58:1999;426-435.
47. Uberti D., Belloni M., Grilli M., Spano P., Memo M. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurons triggered by excitatory amino acids. Eur. J. Neurosci. 10:1998;246-254.
48. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock C., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 302:2003;1036-1038.
49. Vu T.K.H., Hung D.T., Wheaton V.I., Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
50. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2001;2922-2933.
51. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., Dawson V.L. Mediation of poly(ADP-Ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 297:2002;259-263.